| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-05 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.19 | 9e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.27 | 0.0001 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.26 | 0.0002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.33 | 0.0003 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0003 |